SumitGuptaMD

Pediatric Hematology & Oncology • Las Vegas, NV

Pediatric Hematologic Oncology, Pediatric Neuro-Oncology

Physician

Join to view full profile

Dr. Gupta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gupta's full profile

Already have an account?

Office
1 Breakthrough Way
Las Vegas, NV 89135
Phone+1 702-732-1493

Fax+1 702-732-1080

Education & Training

Mount Sinai Hospital Medical Center of ChicagoResidency, Pediatrics, 2015 - 2018
Kasturba Medical College ManipalClass of 2013

Certifications & Licensure

NV State Medical License 2020 - 2025
ME State Medical License 2020 - 2021
PA State Medical License 2018 - 2021
IL State Medical License 2015 - 2018
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

The emerging field of viroimmunotherapy for pediatric brain tumors.
Marc Garcia-Moure, Virginia Laspidea, Sumit Gupta, Andrew G Gillard, Soumen Khatua
Neuro-Oncology. 2024-11-04
1 citations
Case Report: Blinatumomab as upfront consolidation and maintenance therapy in a pediatric patient with high-risk B-cell acute lymphoblastic leukemia.
Sumit Gupta, Jessica Casey, Joseph Lasky
Frontiers in Oncology. 2023-01-01
21 citations
Drug delivery across the blood-brain barrier for the treatment of pediatric brain tumors - An update.
Erica A Power, Julian S Rechberger, Sumit Gupta, Jonathan D Schwartz, David J Daniels
Advanced Drug Delivery Reviews. 2022-06-01

Press Mentions

Blincyto® (Blinatumomab) Added to Chemotherapy Significantly Improves Survival in Newly Diagnosed Pediatric Patients with B-cell Precursor Acute Lymphoblastic Leukemia (B-all)December 8th, 2024
Seattle Children’s Researchers Greatly Improve Survival for Children Diagnosed with the Most Common Form of Childhood Cancer, Changing the Standard of CareDecember 7th, 2024